RecallDepth

Atellica CH Lithium (Li), Siemens Material Number 11097535. in vitro diagnostic assay

Company
Siemens Healthcare Diagnostics, Inc.
Recall Initiated
September 19, 2022
Posted
October 20, 2022
Recall Number
Z-0105-2023
Quantity
586 US; 694 OUS
Firm Location
Tarrytown, NY

Reason for Recall

Potential for falsely elevated LITH_2 and Li results on the Atellica CH 930 Analyzer. In the worst case, there is a potential for erroneously elevated lithium patient results, which may lead to inappropriate dosage adjustment, potentially affecting treatment efficacy.

Distribution

Worldwide distribution - US Nationwide.

Lot / Code Info

UDI-DI: 00630414006789 All lots impacted: Lots 110354 exp 11/15/22 120038 exp 2/7/23

Root Cause

Under Investigation by firm

Action Taken

On September 19, 2022, the firm issued an Urgent Medical Device Correction letter to affected customers. Customers should take the following actions: -Please review this letter with your Medical Director. -Discontinue use of and discard the affected product. Siemens is temporarily discontinuing production and distribution of the Atellica CH lithium reagents until the issue is resolved. In the interim, Siemens is recommending that customers transition to an alternate lithium assay.

More recalls by Siemens Healthcare Diagnostics, Inc.

View all recalls by this company →